ERBB2 and biliary tract cancer: In this review, we discuss the potential therapeutic utilization of HER2-blocking antibodies and ongoing clinical trials assessing the efficacy of HER2-blocking antibodies in HER2-altered and/or -amplified biliary tract cancers.